1. Home
  2. ODC vs MLYS Comparison

ODC vs MLYS Comparison

Compare ODC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODC
  • MLYS
  • Stock Information
  • Founded
  • ODC 1941
  • MLYS 2019
  • Country
  • ODC United States
  • MLYS United States
  • Employees
  • ODC N/A
  • MLYS N/A
  • Industry
  • ODC Miscellaneous manufacturing industries
  • MLYS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODC Consumer Discretionary
  • MLYS Health Care
  • Exchange
  • ODC Nasdaq
  • MLYS Nasdaq
  • Market Cap
  • ODC 310.1M
  • MLYS 634.6M
  • IPO Year
  • ODC N/A
  • MLYS 2023
  • Fundamental
  • Price
  • ODC $42.74
  • MLYS $9.97
  • Analyst Decision
  • ODC
  • MLYS Strong Buy
  • Analyst Count
  • ODC 0
  • MLYS 2
  • Target Price
  • ODC N/A
  • MLYS $30.00
  • AVG Volume (30 Days)
  • ODC 33.8K
  • MLYS 250.2K
  • Earning Date
  • ODC 03-06-2025
  • MLYS 03-20-2025
  • Dividend Yield
  • ODC 1.45%
  • MLYS N/A
  • EPS Growth
  • ODC 36.22
  • MLYS N/A
  • EPS
  • ODC 3.09
  • MLYS N/A
  • Revenue
  • ODC $454,094,000.00
  • MLYS N/A
  • Revenue This Year
  • ODC N/A
  • MLYS N/A
  • Revenue Next Year
  • ODC N/A
  • MLYS N/A
  • P/E Ratio
  • ODC $13.75
  • MLYS N/A
  • Revenue Growth
  • ODC 6.61
  • MLYS N/A
  • 52 Week Low
  • ODC $29.48
  • MLYS $8.58
  • 52 Week High
  • ODC $46.50
  • MLYS $16.91
  • Technical
  • Relative Strength Index (RSI)
  • ODC 54.49
  • MLYS 40.13
  • Support Level
  • ODC $41.51
  • MLYS $9.18
  • Resistance Level
  • ODC $43.79
  • MLYS $10.71
  • Average True Range (ATR)
  • ODC 1.28
  • MLYS 0.84
  • MACD
  • ODC -0.21
  • MLYS -0.05
  • Stochastic Oscillator
  • ODC 50.86
  • MLYS 28.72

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

Share on Social Networks: